- Home
- ROIV vs DDS Comparison
ROIV vs DDS Comparison
Compare ROIV & DDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- DDS
- Stock Information
- Founded
- ROIV 2014
- DDS 1938
- Country
- ROIV United Kingdom
- DDS United States
- Employees
- ROIV N/A
- DDS N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- DDS Department/Specialty Retail Stores
- Sector
- ROIV Health Care
- DDS Consumer Discretionary
- Exchange
- ROIV Nasdaq
- DDS Nasdaq
- Market Cap
- ROIV 8.6B
- DDS 9.2B
- IPO Year
- ROIV N/A
- DDS N/A
- Fundamental
- Price
- ROIV $16.17
- DDS $615.32
- Analyst Decision
- ROIV Strong Buy
- DDS Sell
- Analyst Count
- ROIV 8
- DDS 3
- Target Price
- ROIV $19.94
- DDS $394.33
- AVG Volume (30 Days)
- ROIV 9.5M
- DDS 115.5K
- Earning Date
- ROIV 11-11-2025
- DDS 11-13-2025
- Dividend Yield
- ROIV N/A
- DDS 4.22%
- EPS Growth
- ROIV N/A
- DDS N/A
- EPS
- ROIV N/A
- DDS 36.31
- Revenue
- ROIV $23,233,000.00
- DDS $6,585,750,000.00
- Revenue This Year
- ROIV N/A
- DDS N/A
- Revenue Next Year
- ROIV $248.22
- DDS N/A
- P/E Ratio
- ROIV N/A
- DDS $16.97
- Revenue Growth
- ROIV N/A
- DDS N/A
- 52 Week Low
- ROIV $8.73
- DDS $282.24
- 52 Week High
- ROIV $16.19
- DDS $637.73
- Technical
- Relative Strength Index (RSI)
- ROIV 80.34
- DDS 61.83
- Support Level
- ROIV $14.86
- DDS $609.31
- Resistance Level
- ROIV $16.15
- DDS $637.73
- Average True Range (ATR)
- ROIV 0.43
- DDS 19.34
- MACD
- ROIV 0.06
- DDS -1.30
- Stochastic Oscillator
- ROIV 99.12
- DDS 66.00
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About DDS Dillard's Inc.
Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. Its stores offer a large variety of merchandise and feature products from both national and exclusive brand sources. The company also operates a general contracting construction company, CDI Contractors. CDI Contractors' business includes constructing and remodelling stores for Dillards. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company operates in two business segments; Retail Operations and Construction. The Retail Operations segment generates maximum revenue for the company.